{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:05:02Z","timestamp":1789761902303,"version":"4.0.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.idnow.2026.105314","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:02:56Z","timestamp":1781798576000},"page":"105314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subcutaneous antibiotic therapy: effectiveness and safety in a real-world cohort of 136 patients"],"prefix":"10.1016","volume":"56","author":[{"given":"Marie","family":"JUMPERTZ","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piseth","family":"SENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"CORTAREDONA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"LAVRARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"STEIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim","family":"CASSIR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2026.105314_bb0005","doi-asserted-by":"crossref","first-page":"370.e1","DOI":"10.1016\/j.cmi.2014.11.017","article-title":"Subcutaneously administered antibiotics: a national survey of current practice from the French infectious diseases (SPILF) and geriatric medicine (SFGG) society networks","volume":"21","author":"Forestier","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.idnow.2026.105314_bb0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.medmal.2019.06.007","article-title":"Subcutaneously administered antibiotics","volume":"50","author":"Colin","year":"2020","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.idnow.2026.105314_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkac383","article-title":"Complete genome sequence and characterization of Clostridium perfringens type D carrying optrA-plasmid and Tn6218-like transposon","volume":"78","author":"Jumpertz","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.idnow.2026.105314_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciag088","article-title":"New French guidelines on subcutaneous antibiotic therapy: a response to Di Bella et al","author":"Forestier","year":"2026","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.idnow.2026.105314_bb0025","first-page":"50","article-title":"A sustainable interdisciplinary approach to the appropriate use of antipsychotic medications in long-term care","volume":"22","author":"Hernandez-Ruiz","year":"2021","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.idnow.2026.105314_bb0030","article-title":"Outpatient subcutaneous antimicrobial therapy (OSCAT) as a measure to improve the quality and efficiency of healthcare delivery for patients with serious bacterial infections","volume":"7","author":"Ferry","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.idnow.2026.105314_bb0035","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/jgs.18786","article-title":"Safety of subcutaneous versus intravenous ceftriaxone administration in older patients: a retrospective study","volume":"72","author":"Pardo","year":"2024","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.idnow.2026.105314_bb0040","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.medmal.2012.07.005","article-title":"Pasteurella multocida\u00a0: une \u00e9tiologie rare d\u2019abc\u00e8s c\u00e9r\u00e9bral","volume":"42","author":"Forestier","year":"2012","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.idnow.2026.105314_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1955-7","article-title":"Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration","volume":"16","author":"Peeters","year":"2016","journal-title":"BMC Infect. Dis."},{"issue":"10","key":"10.1016\/j.idnow.2026.105314_bb0050","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1128\/AAC.00351-16","article-title":"Tolerability and plasma drug level monitoring of prolonged subcutaneous teicoplanin treatment for bone and joint infections","volume":"60","author":"El Samad","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.idnow.2026.105314_bb0055","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41585-020-0362-4","article-title":"Epidemiology, definition and treatment of complicated urinary tract infections","volume":"17","author":"Wagenlehner","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.idnow.2026.105314_bb0060","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.medmal.2018.02.004","article-title":"Sporotrichoid non-tuberculous mycobacterial infections following anti-TNF treatment","volume":"48","author":"Laurent","year":"2018","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.idnow.2026.105314_bb0065","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/jac\/dkq445","article-title":"Outpatient parenteral antibiotic therapy for bone and joint infections: experience from a UK teaching hospital-based service","volume":"66","author":"Mackintosh","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.idnow.2026.105314_bb0070","first-page":"3178","article-title":"Therapeutic drug monitoring of the \u03b2-lactam antibiotics: what is the evidence and which patients should we be using it for?","volume":"70","author":"Huttner","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.idnow.2026.105314_bb0075","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaf691","article-title":"When and how to use subcutaneous antibiotics","author":"Di Bella","year":"2026","journal-title":"Clin. Infect. Dis."}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991926000710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991926000710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:15:56Z","timestamp":1789758956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991926000710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666991926000710"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2026.105314","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous antibiotic therapy: effectiveness and safety in a real-world cohort of 136 patients","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2026.105314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105314"}}